SOFINNOVA PARTNERS SAS purchased 3.3% of their position (133.33K shares) of CINCOR PHARMA, INC. on the open market
Open‑market purchase worth $4.00M — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/17/2022ACC: 0001209191-22-046250
10% Owner
Since Jan 2022
+133.33K
Net shares
Net buyer
$4.00M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
133.33K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+133.33K
Price / share
$30.00
Trade value
$4M
% of position
3.3%
8/15/2022
4.09M→4.22M
Total
Net shares
+133.33K
Net value
$4M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/15/2022 | P · Purchase | +133.33K | $30.00 | $4M | 3.3% | 4.09M | 4.22M |
| Total | +133.33K | $4M | ||||||
Derivative Transactions0
No derivative transactions reported